T1	Participants 34 87	long-term exogenous subclinical hyperthyroid patients
T2	Participants 679 814	Totally 25 patients with a history of differentiated thyroid carcinoma on long-term TSH-suppressive levothyroxine (l-T(4)) substitution
T3	Participants 929 976	Additionally 40 euthyroid controls were studied
